Immunoassay for Neurological Biomarkers Market Research 2026 - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030 [Yahoo! Finance]
Qiagen N.V. Common Shares (QGEN)
Last qiagen n.v. common shares earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corporate.qiagen.com/investor-relations
Company Research
Source: Yahoo! Finance
demand for early diagnostics, AI integration enhancing biomarker detection, and personalized therapies. Challenges include regulatory hurdles and standardization complexity. Key players include QIAGEN NV, Abbott, and Merck. Immunoassay for Neurological Biomarkers Market Immunoassay for Neurological Biomarkers Market · GlobeNewswire Inc. Dublin, Feb. 26, 2026 (GLOBE NEWSWIRE) -- The "Immunoassay for Neurological Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030" has been added to ResearchAndMarkets.com's offering. The Global Immunoassay for Neurological Biomarkers Market, valued at USD 654.22 Million in 2024, is projected to experience a CAGR of 11.65% to reach USD 1.26 billion by 2030. Immunoassays for neurological biomarkers encompass protein-based tests designed to detect and quantify specific molecular interactions indicative of neurological disorders within biological samples. The global market for these diagnostics is primaril
Show less
Read more
Impact Snapshot
Event Time:
QGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QGEN alerts
High impacting Qiagen N.V. Common Shares news events
Weekly update
A roundup of the hottest topics
QGEN
News
- Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell RecoveryBusiness Wire
- Qiagen (NYSE:QGEN) was given a new $52.00 price target on by analysts at UBS Group AG.MarketBeat
- Qiagen (NYSE:QGEN) had its price target raised by analysts at JPMorgan Chase & Co. from $55.00 to $60.00. They now have an "overweight" rating on the stock.MarketBeat
- Qiagen (NYSE:QGEN) had its price target lowered by analysts at Citigroup Inc. from $55.40 to $55.00. They now have a "neutral" rating on the stock.MarketBeat
- Qiagen (NYSE:QGEN) was given a new $53.00 price target on by analysts at Robert W. Baird.MarketBeat
QGEN
Earnings
- 2/4/26 - Beat
QGEN
Sec Filings
- 2/10/26 - Form SCHEDULE
- 2/6/26 - Form SCHEDULE
- 2/6/26 - Form 6-K
- QGEN's page on the SEC website